FORM 8.3 – WILLIS TOWERS WATSON PLC

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 28 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,862,052

1.44%

228,687

0.18%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

94,581

0.07%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,940,511

1.50%

329,368

0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

261.7600 USD

Purchase

10

262.4300 USD

Purchase

34

262.9700 USD

Purchase

41

262.2500 USD

Purchase

100

261.3700 USD

Purchase

100

261.9300 USD

Purchase

165

262.1263 USD

Purchase

200

261.6200 USD

Purchase

200

261.7875 USD

Purchase

400

261.3075 USD

Purchase

700

261.6742 USD

Purchase

779

261.4778 USD

Purchase

900

261.4475 USD

Purchase

1,307

261.8607 USD

Purchase

1,327

261.8587 USD

Purchase

1,827

261.5490 USD

Purchase

2,169

261.8225 USD

Purchase

2,250

261.3491 USD

Purchase

5,712

261.4582 USD

Purchase

5,735

261.3600 USD

Purchase

10,000

261.7900 USD

Purchase

11,708

261.3623 USD

Purchase

11,840

261.3861 USD

Sale

37

261.5400 USD

Sale

78

261.5433 USD

Sale

100

261.9700 USD

Sale

100

262.3700 USD

Sale

100

261.5900 USD

Sale

252

261.6541 USD

Sale

304

261.5180 USD

Sale

403

261.6953 USD

Sale

842

261.6633 USD

Sale

855

261.6907 USD

Sale

924

261.9300 USD

Sale

1,100

261.2218 USD

Sale

1,500

261.4372 USD

Sale

1,665

261.4983 USD

Sale

2,005

261.5125 USD

Sale

2,250

261.3491 USD

Sale

2,995

261.7200 USD

Sale

5,697

261.3600 USD

Sale

6,976

261.5315 USD

Sale

7,681

261.5425 USD

Sale

10,000

261.7900 USD

Sale

11,746

261.3623 USD

Sale

11,827

261.7527 USD

Sale

12,519

261.4309 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

31 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

 

date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 738264
Time of Receipt (offset from UTC): 20210531T145331+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC